Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
SCC77: Bloomage Bloomsurfact EncapCare RP Ensures 99% Dispersion of Anti-aging Ingredient
Details : Bloomsurfact EncapCare (hyaluronic acid) is an emulsion solution for effective anti-aging skin rejuvenation & ensures high bioavailability & low irritation making it more friendly for sensitive skin.
Brand Name : Bloomsurfact EncapCare
Molecule Type : Small molecule
Upfront Cash : Not Applicable
December 12, 2023
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Hyanutra™-RH Hair Nourishing Shield is a new hair moisturizing conditioner made from HA with different molecular weights and brown rice ferment filtrate by patented technology. It is especially suitable for damaged hair.
Brand Name : Hyanutra
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 29, 2023
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Sodium Hyaluronate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Approved
Sponsor : Lumenis
Deal Size : Not Applicable
Deal Type : Not Applicable
Lumenis and Bloomage Biotech jointly released a new product - M22 medical wound dressing
Details : M22 medical wound dressing (sodium hyaluronate) is a versatile laser treatment system based on Lumenis' medical beauty concept of "30% Laser Treatment and 70% Postoperative care.
Brand Name : M22 Medical Wound Dressing
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 10, 2023
Lead Product(s) : Sodium Hyaluronate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved
Sponsor : Lumenis
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Zinc Hyaluronate
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Hybloom Zinc Hyaluronate and Hyanutra-RH Hair Nourishing Shield won Fountain Awards
Details : Hybloom (zinc hyaluronate) also known as HA-Zn, which canbe used to treat acne and allergy. It received Fountain Awards" for Acne/Allergy Alleviation and Hair/Scalp Care respectively.
Brand Name : Hybloom
Molecule Type : Small molecule
Upfront Cash : Not Applicable
February 20, 2023
Lead Product(s) : Zinc Hyaluronate
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Hyanutra™ RH Hair Nourishing Shield-Innovation Hyaluronic Acid Hair Care Solution
Details : Hyanutra™-RH Hair Nourishing Shield is a new hair moisturizing conditioner made from HA with different molecular weights and brown rice ferment filtrate by patented technology. It is especially suitable for damaged hair.
Brand Name : Hyanutra
Molecule Type : Small molecule
Upfront Cash : Not Applicable
December 02, 2022
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Ectoine
Therapeutic Area : Immunology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Bloomecto™ Ectoine -- Nasal Spray New Solution
Details : Bloomecto (ectoine) is an osmoprotectant which form a hydration layer outside the cells, reduce the impact of allergens on cells, ease the development of inflammation.
Brand Name : Bloomecto
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 30, 2022
Lead Product(s) : Ectoine
Therapeutic Area : Immunology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Helicobacter Pylori
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
2022 FIC Exhibition | Bloomage Biotech Launches AbateHP™- the New Anti-Helicobacter Pylori Solution
Details : AbateHP™, Bloomage Biotech fully demonstrated the application of sodium hyaluronate in oral beauty, bone and joint maintenance, intestinal health and other fields.
Brand Name : AbateHP
Molecule Type : Large molecule
Upfront Cash : Not Applicable
August 19, 2022
Lead Product(s) : Helicobacter Pylori
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Neurology
Study Phase : Approved
Recipient : Medytox
Deal Size : Undisclosed
Deal Type : Termination
Medytox’s Chinese Partner Terminates BTX Deal
Details : Medytox applied for a license for Meditoxin (export name: Neuronox having Clostridium Botulinum Toxin type A), Medytox’s BTX product, to China’s National Medical Products Administration in February 2018.
Brand Name : Neuronox
Molecule Type : Large molecule
Upfront Cash : Undisclosed
August 04, 2022
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Neurology
Highest Development Status : Approved
Recipient : Medytox
Deal Size : Undisclosed
Deal Type : Termination
Lead Product(s) : Mesenchymal Stem Cells-based Therapy
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Rohto Pharmaceutical
Deal Size : Undisclosed
Deal Type : Partnership
Chinese Company Bloomage Biotech Forges Partnership with Japanese Firms on Regenerative Medicine
Details : The joint venture will be settled in the Haikou National High-tech Zone of south China's Hainan Province, and will focus on research in regenerative medicine and cell culture medium, mesenchymal stem cells-based therapies, as well as related commercial o...
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 24, 2022
Lead Product(s) : Mesenchymal Stem Cells-based Therapy
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Rohto Pharmaceutical
Deal Size : Undisclosed
Deal Type : Partnership